John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 8,045 shares at $74.90 ($498K) on 2015-09-22, disclosed to the SEC on 2015-09-23.
Open-market sale of $498k KYTH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,400 | $0 | 0.0% |
| 2 | $74.95 | 1,054 | $79K | 15.9% |
| 3 | $74.90 | 2,115 | $158K | 31.8% |
| 4 | $74.90 | 3,476 | $260K | 52.3% |
| Total | $61.87 avg | 8,045 | $498K | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |